Related Experiment Video
Updated: Dec 23, 2025

Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
Published on: October 29, 2013
Glycopeptide Hypersensitivity and Adverse Reactions
Vanthida Huang1, Nicola A Clayton2, Kimberly H Welker3
1Department of Pharmacy Practice, Midwestern University College of Pharmacy-Glendale, Glendale, AZ 85308, USA.
Abstract:
Glycopeptides, such as vancomycin and teicoplanin, are primarily used in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections, such as cellulitis, endocarditis, meningitis, pneumonia, and septicemia, and are some of the most commonly prescribed parenteral antimicrobials. Parenteral glycopeptides are first-line therapy for severe MRSA infections; however, oral vancomycin is used as a first-line treatment of Clostridioides difficile infections. Also, we currently have the longer-acting lipoglycopeptides, such as dalbavancin, oritavancin, and telavancin to our armamentarium for the treatment of MRSA infections. Lastly, vancomycin is often used as an alternative treatment for patients with β-lactam hypersensitivity. Common adverse effects associated with glycopeptide use include nephrotoxicity, ototoxicity, and Redman Syndrome (RMS). The RMS is often mistaken for a true allergy; however, it is a histamine-related infusion reaction rather than a true immunoglobulin E (IgE)-mediated allergic reaction. Although hypersensitivity to glycopeptides is rare, both immune-mediated and delayed reactions have been reported in the literature. We describe the various types of glycopeptide hypersensitivity reactions associated with glycopeptides and lipoglycopeptides, including IgE-mediated reactions, RMS, and linear immunoglobulin A bullous dermatosis, as well as describe cross-reactivity with other glycopeptides.
Insights
Glycopeptides like vancomycin treat MRSA infections and C. difficile. Hypersensitivity reactions, including Redman Syndrome, are rare but important to recognize and manage.
Area of Science:
- Pharmacology
- Infectious Diseases
- Immunology
Background:
- Glycopeptides (vancomycin, teicoplanin) and lipoglycopeptides (dalbavancin, oritavancin, telavancin) are crucial for treating MRSA infections.
- Parenteral glycopeptides are first-line for severe MRSA, while oral vancomycin treats C. difficile infections.
- Vancomycin serves as an alternative for patients with beta-lactam hypersensitivity.
Purpose of the Study:
- To review and describe various hypersensitivity reactions to glycopeptides and lipoglycopeptides.
- To differentiate true allergic reactions from infusion-related events like Redman Syndrome.
- To discuss cross-reactivity patterns among these antimicrobial agents.
Main Methods:
- Literature review of glycopeptide and lipoglycopeptide hypersensitivity.
- Analysis of reported cases of immune-mediated and delayed reactions.
- Categorization of reactions including IgE-mediated, Redman Syndrome, and linear IgA bullous dermatosis.
Main Results:
- Common adverse effects include nephrotoxicity, ototoxicity, and Redman Syndrome (RMS).
- RMS is a histamine-mediated infusion reaction, not a true IgE-mediated allergy.
- Immune-mediated and delayed hypersensitivity reactions to glycopeptides are reported, with potential cross-reactivity.
Conclusions:
- Understanding the spectrum of glycopeptide hypersensitivity is vital for safe clinical practice.
- Distinguishing RMS from true allergy is key to appropriate patient management.
- Awareness of cross-reactivity is important when selecting alternative therapies.
Related Concept Videos
Hypoglycemia and Glucagon
Proteoglycans
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions
Protein Glycosylation
Glycosylation occurs in...
Desensitization and Tachyphylaxis

